Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Approach to Radiotherapy in Locally Advanced Lung Cancer - Heterogeneous FDG-guided Dose Escalation With Concomitant Navelbine®

NCT02354274 is registered in ClinicalTrials.gov with Olfred Hansen as lead sponsor.

NCT NCT02354274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02354274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Approach to Radiotherapy in Locally Advanced Lung Cancer - Heterogeneous FDG-guided Dose Escalation With Concomitant Navelbine®
Lead sponsor
Olfred Hansen
Phase
Not applicable
Overall status
Recruiting
Start date
January 31, 2015
Completion date
October 31, 2029
Enrollment
330 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc